Plain-English translation of NCT05124288 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at why acute myeloid leukemia sometimes comes back after patients receive a stem cell transplant. Researchers will study blood and tissue samples from patients whose leukemia has relapsed to understand the biological reasons behind the relapse. This information will help doctors develop more personalized treatment plans tailored to each patient's specific situation.
When leukemia returns after a transplant, doctors don't always understand exactly why it happened or what the best next treatment should be. This study aims to fill that gap by deeply analyzing the biology of relapsed cases, so doctors can create targeted treatment strategies that work better for each individual patient.
You likely qualify if…
You likely don't qualify if…
Your participation will involve donating blood and tissue samples that researchers will analyze in detail to understand your specific type of leukemia relapse. The study also involves collecting information from your standard medical care and records. This is not an intervention study where you receive a new treatment — instead, researchers are learning from your samples to help inform better treatment options for future patients.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Italy